LifeTech Scientific Corporation

Equities

1302

KYG548721177

Advanced Medical Equipment & Technology

Delayed Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
1.76 HKD +0.57% Intraday chart for LifeTech Scientific Corporation 0.00% -25.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue MT
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
LifeTech Scientific Flags Significant Profit Drop in 2023 MT
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
LifeTech Scientific to Grant 174.8 Million Share Options MT
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter MT
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue MT
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Grants Official Registration Approval for LifeTech Scientific's Surgical Navigation System MT
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA CI
Jenscare Scientific, LifeTech Complete Treatment for Valve Replacement Product; Jenscare Shares Rise 3% MT
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo MT
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System MT
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed CI
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System CI
LifeTech Scientific Logs 68.6% Drop in 2022 Profit MT
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Lifetech Scientific and Jenscare Scientific to Cooperate on Business Development MT
LifeTech Scientific Corporation Enters Strategic Cooperation Agreement with Jenscare Scientific Co., Ltd CI
Lifetech Scientific Completes Patient Enrollment for China Phase II Clinical Trial of Coronary Scaffold System MT
LifeTech Scientific Corporation Announces Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed CI
LifeTech Scientific’s Aortic Stent Graft Admitted into China's Special Approval Procedure MT
Jenscare Scientific Raises Nearly $20 Million in Hong Kong IPO MT
Jenscare Scientific Anticipates Up to $30 Million in Hong Kong IPO MT
LifeTech Scientific's Heart Appendage Closure System Gets US Medical Insurance Coverage MT
Chart LifeTech Scientific Corporation
More charts
LifeTech Scientific Corporation is an investment holding company principally engaged in the manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.625 CNY
Average target price
2.971 CNY
Spread / Average Target
+82.80%
Consensus

Annual profits - Rate of surprise